NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the...
Oncology innovations and cancer care treatment are complex, exceeding an estimated $200 billion in 2020. As cancer research constantly develops new...
There is a disconnect between what patients and physicians believe to be unfair treatment in the context of cancer care....
We welcome Dr. Tiffany Avery, Chief Medical Officer for NantHealth for a in-depth discussion on the multi-factor nature of healthcare....
Podcast Episode 43: Health Disparities in Oncology and Beyond with Dr. Tiffany Avery, Chief Medical Officer, NantHealth We welcome Dr....
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
Oncology has a lot on its plate. As cancer care is welcoming a bounty of new treatments, it is absorbing...
NantHealth’s study data shows: Adoption of trastuzumab biosimilars in treatment of HER2-positive breast cancer is significant; does not appear to...
The COVID-19 pandemic has abruptly and fundamentally changed our lives, with specific, evolving impacts on healthcare. Our initial responses were...
Healthcare is an ever-evolving field that continues to grow and adapt based on research, the ability to analyze data, and...
For payers, Eviti Connect streamlines the authorization of cancer treatment, ensuring prescription of high-quality, high-value care and setting patients on...
As an Air Force pilot, the jets I flew all came with User’s Manuals, but unlike the one in your...